Some biotech stocks follow the old maxim that “what goes up will come down.” Others, though, adhere to a more upbeat principle: winners win.
We asked three Motley Fool contributors to pick biotech stocks that have soared in 2021 and could go even higher in 2022. Here’s why they chose BioNTech (NASDAQ: BNTX), Eli Lilly (NYSE: LLY), and Novavax (NASDAQ: NVAX).
Image source: Getty Images.